FORIAN INC.

FORA

CIK 0001829280 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$8M
↑+37.0% +$2Mvs FY2024 (Q4)
Operating Income
$3M
↑+0.4% +$12Kvs FY2024 (Q4)
Net Income
$3M
↑+2.3% +$62Kvs FY2024 (Q4)
Gross Profit
$4M
↑+15.6% +$527Kvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Average
56/100
  • Profitability
    0ROIC -9.9% (10% = solid, 20%+ = moat)
  • Liquidity
    100Current Ratio 2.97 (above 1.5 = solid)
  • Leverage
    0Insufficient data
  • Efficiency
    36Asset Turnover 0.66x (1.0+ = capital-efficient)
  • Growth
    100Revenue YoY +37.0% (10% = solid, 25%+ = elite)
  • Margin Trend
    100Op Margin -6.1% · trend +30.1pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project FORA's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

25%

Trailing 3-yr CAGR was 32.1%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$3.09
Total enterprise IV
$96M
Diluted shares
0.03B
Terminal PV
$75M (78% of total)
Year-5 FCF
$9M
YearProjected FCFDiscounted PV
+1$4M$3M
+2$5M$4M
+3$6M$4M
+4$7M$5M
+5$9M$5M
Terminal$120M$75M

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
investment in PP&E
Stock buybacks (TTM)
share count reduction
Stock-based comp (TTM)
$3M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$44M
everything owned
Total liabilities
$14M
everything owed
Stockholders' equity
$30M
shareholder claim

Recent performance · 25 quarters

Revenue↑+37.0% +$2M
$8M
Net Income↑+26.2% +$54K
$-151K
Free Cash Flow↑+84.2% +$1M
$3M
Operating Margin↑+10.9pts
-6.1%

Drill down